New Guidelines for Type 1 Diabetes in Adults: An Overview

This transcript has been edited for clarity.

Today we presented the draft guidelines for the treatment of type 1 diabetes (T1D) at the American Diabetes Association (ADA) Scientific Sessions. They were just draft guidelines, so it's not gospel, and the actual final guidelines are going to be presented at the European Association for the Study of Diabetes (EASD) meeting this fall. It's important to note that you have 10 days in which to give us your comments.

Let me tell you the story of how these guidelines began. Dr Richard Holt, who's in the UK, decided that we need a set of guidelines for the management of T1D because, frankly, it was always under the shadow of the treatment of people with type 2 diabetes (T2D). Also in part because the guidelines for the treatment of T2D have been really well established and accepted around the world.

He decided to set forth an ADA/EASD committee. He chose 14 people from around the United States and Europe — seven from the US and seven from Europe. The first meeting was the EASD group alone, and they met in January 2020; the first combined group was in March 2020. We all had visions of European meetings and everything else, but of course that didn't happen.